The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 210.40
Bid: 209.00
Ask: 209.60
Change: 9.80 (4.89%)
Spread: 0.60 (0.287%)
Open: 197.70
High: 210.60
Low: 197.70
Prev. Close: 200.60
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Rule 2.8 termination announcement

22 Mar 2024 18:28

RNS Number : 0482I
Direct Line Insurance Group PLC
22 March 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

22 March 2024

Direct Line Insurance Group plc ("Direct Line Group" or the "Company")

Response to Rule 2.8 termination announcement from Ageas SA/NV ("Ageas")

The Board of Direct Line Group (the "Board") notes the announcement from Ageas confirming that it does not intend to make an offer for Direct Line Group. As a result, Ageas is bound by the restrictions set out in Rule 2.8 of the Takeover Code.

The Board is confident in Direct Line Group's standalone prospects. As communicated at Direct Line Group's 2023 preliminary results on 21 March 2024, the Board believes under Adam Winslow's leadership the Company is well-positioned to drive material improvement in performance that is expected to unlock significant value for Direct Line Group shareholders.

For further information, please contact:

Direct Line Group

Paul Smith

Director of Business Performance and Investor Relations

Email: paul.r.smith@directlinegroup.co.uk

Tel: +44 (0)7795 811263

Alan Oliver

Group Communications

Email: alan.oliver@directlinegroup.co.uk

Tel: +44 (0)7385 481295

Publication on website

A copy of this announcement will be made available on the Company's website at directlinegroup.co.uk by no later than 12 noon (London time) on the business day following the date of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated into and do not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RSPFLFFTVRIFFIS
Date   Source Headline
30th Aug 20237:00 amRNSAppointment of CEO
28th Jul 20234:00 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSResponse to press coverage
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
1st Jun 20235:00 pmRNSNotice of Results
31st May 20233:00 pmRNSDirector/PDMR Shareholding
30th May 20236:30 pmRNSDirector/PDMR Shareholding
30th May 20235:30 pmRNSDirector/PDMR Shareholding
12th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20233:00 pmRNSResult of AGM
9th May 20237:00 amRNSTrading Update for Q1 2023
28th Apr 20233:00 pmRNSDirector/PDMR Shareholding
25th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20234:00 pmRNSHolding(s) in Company
3rd Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:00 pmRNSNotice of 2023 AGM
31st Mar 20233:00 pmRNSHolding(s) in Company
31st Mar 20232:30 pmRNS2022 Solvency and Financial Condition Report
30th Mar 20233:00 pmRNSAppointment to Board Committees
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
24th Mar 20239:30 amRNS2022 Annual Report and Accounts
20th Mar 20234:00 pmRNSHolding(s) in Company
14th Mar 20236:30 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSPreliminary Results year ended 31 December 2022
10th Mar 202310:15 amRNSDirector Declaration
1st Mar 20235:00 pmRNSHolding(s) in Company
28th Feb 20234:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20236:15 pmRNSHolding(s) in Company
17th Feb 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSNotice of 2022 preliminary results
30th Jan 20233:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirect Line Group executes strategic reinsurance
16th Jan 20236:00 pmRNSHolding(s) in Company
12th Jan 20233:00 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
29th Dec 202212:00 pmRNSDirector/PDMR Shareholding
13th Dec 20224:00 pmRNSHolding(s) in Company
12th Dec 20227:00 amRNSIFRS 17 update
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSTrading Update for Q3 2022
28th Oct 20225:30 pmRNSDirector/PDMR Shareholding
10th Oct 202211:30 amRNSChange of Auditor
28th Sep 20226:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20223:00 pmRNSDirector/PDMR Shareholding
13th Sep 20224:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.